Skip to main content

Table 2 The association between the risk of NAFLD and the genetic polymorphisms

From: Genetic polymorphisms associated with nonalcoholic fatty liver disease in Uyghur population: a case-control study and meta-analysis

SNP WT Ho/ Ht/ VR Ho VR Ho vs WT Ho Ht vs WT Ho Dominant model Recessive model VR allele vs WT allele
Control NAFLD P OR (95%CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI)
rs1260326 115/145/43 103/149/65 0.03 1.69 (1.06–2.70) 0.09 1.15 (0.81–1.63) 0.15 1.27 (0.91–1.77) 0.04 1.56 (1.02–2.38) 0.04 1.27 (1.01–1.59)
rs780094 120/137/46 101/150/66 0.02 1.70 (1.08–2.70) 0.06 1.30 (0.92–1.85) 0.04 1.40 (1.01–1.95) 0.07 1.47 (0.97–2.22) 0.02 1.30 (1.04–1.63)
rs2954021 94/144/65 82/173/62 0.20 1.09 (0.69–1.73) 0.09 1.38 (0.95–1.99) 0.15 1.29 (0.91–1.83) 0.56 0.89 (0.60–1.32) 0.56 1.07 (0.85–1.34)
rs2228603 242/57/4 253/58/6 0.58 1.43 (0.40–5.15) 0.84 0.97 (0.65–1.46) 0.99 1.00 (0.68–1.49) 0.57 1.44 (0.40–5.16) 0.86 1.03 (0.73–1.46)
rs58542926 268/34/1 270/44/3 0.35 2.98 (0.31–28.81) 0.36 1.28 (0.80–2.07) 0.23 1.33 (0.83–2.13) 0.33 2.89 (0.30–27.89) 0.18 1.35 (0.87–2.09)
rs12137855 200/96/7 223/83/11 0.49 1.41 (0.54–3.71) 0.25 0.78 (0.55–1.10) 0.25 0.82 (0.58–1.15) 0.39 1.52 (0.58–3.97) 0.46 0.89 (0.67–1.20)
rs10883437 175/115/13 168/134/15 0.64 1.20 (0.56–2.60) 0.49 1.21 (0.88–1.68) 0.23 1.21 (0.88–1.67) 0.79 1.11 (0.52–2.37) 0.27 1.17 (0.89–1.53)
  1. OR odds ratio; VR variant; WT wild-type; Ht heterozygote; VR Ho, variant homozygote; WT Ho, wide-type homozygote